Medtronic’s Record Mazor Sales Temper Overall Declines Company Revenue The Numbers Record Mazor robot sales, combined with near-record imaging and navigation sales, helped MDT offset COVID-related core spine declines. Feb 24, 2021
Integra Finishes Orthopedics Run with Double-Digit Losses in 2020 Company Revenue The Numbers The company's orthopedics business declined -13.1% in 2020. Integra closed the divesture of its ortho business to SNN in early 2021. Feb 22, 2021
Amplitude’s Foot and Ankle Business Continues Rapid Growth Company Revenue The Numbers Despite pandemic-related surgical restrictions in its key markets, Amplitude's foot & ankle business grew 30% in FY 2Q21. Feb 22, 2021
Smith+Nephew Loses Knee Replacement Traction in 4Q20 Company Revenue The Numbers The company started 4Q20 with momentum, but COVID restrictions from mid-October derailed efforts in the U.S. and large European markets. Feb 19, 2021
DJO Bullish on Reconstruction Business in 2021 Company Revenue The Numbers Armed with its newly assembled dedicated foot and ankle business, DJO expects double-digit growth in 2021 compared to 2019. Feb 19, 2021
Globus Sets Revenue Records to Close 2020 Company Revenue The Numbers The company set records for total sales and enabling technology in 4Q20, pushing Globus to an all-time high revenue mark for the full year. Feb 18, 2021
Vafa Jamali Tapped to Lead Zimmer Biomet’s Spine and Dental Spin Off Company Updates Competitive Landscape Zimmer Biomet has appointed Vafa Jamali as CEO of its newly formed spine and dental spin off company, NewCo. Feb 18, 2021
Zimmer Biomet Expects First Quarter Declines in 2021, Spins off Spine Business Company Revenue The Numbers Despite performing better than many peers in 4Q20 (-1.5%), the company expects more pandemic-related declines in the first quarter of 2021. Feb 08, 2021
Seikagaku Weathers Another Quarter of Losses Company Revenue The Numbers Despite some volume increases in Japan and the U.S., the company continued to slide due to COVID and erosion of the 5-injection HA market. Feb 08, 2021
Bioventus Launches New Initial Public Offering Investments The Numbers The company announced its second IPO try today with an initial public offering of its Class A common stock targeting $100 million in proceeds. Feb 04, 2021